Source: Virtual Congress 2020 – Management issues in thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
C. Doig (Chertsey, United Kingdom), C. Butter (Chertsey, United Kingdom), N. Hadjisavvas (Chertsey, United Kingdom), S. Saikia (Chertsey, United Kingdom), A. Fawzi (Chertsey, United Kingdom), M. Hewish (Chertsey, United Kingdom), S. Sharma (Chertsey, United Kingdom). Assessing the role of pleural fluid in current cancer diagnostic pathway.. 2923

Member's Comments

No comment yet.

Related content which might interest you: Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 The UK timed diagnostic lung cancer pathway: a pleural disaster Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Diagnostic role of biology markers in 75 patients with pleural effusion Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Reumathoid factor: diagnostic utility in pleural fluid Source: Eur Respir J 2003; 22: Suppl. 45, 191s Year: 2003 The role of diagnostic thoracoscopy in patients with lung cancer and pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 542s Year: 2003 The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 The role of a dedicated chest x-ray reporting tool in the lung cancer diagnostic pathway Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards Source: Eur Respir J 2001; 18: Suppl. 33, 62s Year: 2001 Clinical usefulness of the novel drug sensitivity test for malignancy using pleural effusion Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006 Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Investigating unilateral pleural effusions: the role of cytology. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Evaluation of the role of bronchoscopy in the diagnosis of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 The role of CTPA in investigating a patient with a pleural effusion of unknown etiology Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021 How much of a role does immunohistochemistry have in reaching a final diagnosis of pleural malignancy in routine clinical practice? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Negative predictive value of pleural fluid cytology in patients with a background of cancer. Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019